TRPV1 and arthritic joint disease: Genetic ablation of TRPV1 in mice reduced pain in an adjuvant-induced arthritis model [30] and IP injection of the TRPV1 antagonists, A-889425 and JNJ-17203212, reduced pain behaviors in the monoiodoacetate-induced OA model [29, 43].